RESEARCH ARTICLE
Genetic Polymorphism of Cytochrome p450 (2C9) Enzyme in Iranian Baluch Ethnic Group
Mojdeh Ghiyas Tabari1, Fatemeh Naseri2, Maryam Agh Ataby3, Abdoljalal Marjani4, *
3 Fatima Alzahra Hospital Minodasht, Golestan University of Medical Sciences, Gorgan, Golestan Province,
Iran
4 Department of Biochemistry and Biophysics, Metabolic Disorders Research Center, Gorgan Faculty of Medicine,
Golestan University of Medical Sciences, Gorgan, Golestan province, Iran
Article Information
Identifiers and Pagination:
Year: 2015Volume: 9
First Page: 37
Last Page: 41
Publisher ID: TOBIOCJ-9-37
DOI: 10.2174/1874091X20150609E001
Article History:
Received Date: 28/1/2015Revision Received Date: 10/5/2015
Acceptance Date: 11/5/2015
Electronic publication date: 9/6/2015
Collection year: 2015
open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Abstract
The aim of the present study is to assess and compare the frequencies of the cytochrome P450 CYP2C9 variations in the Baluch ethnic group (n=110) with other ethnic groups. The allele frequencies of CYP2C9*1, CYP2C9*2 and CYP2C9*3 were 80.90%, 11.82% and 7.27%, respectively. 70.90%, 11.82%, 8.18%, 4.55%, 2.73% and 1.82% of subjects were with CYP2C9*1/*1, CYP2C9*1/*2, CYP2C9*1/*3, CYP2C9*2/*2, CYP2C9*2/*3 and CYP2C9*3/*3 genotypes, respectively. Different mutants may effect on prediction of drug dose requirements in different ethnic groups. Thus, CYP2C9 variants to be determined for findings high risk groups use optimal dosage of drugs metabolized by this polymorphic enzyme.
Keywords: Baluch ethnic group, CYP2C9 genetic polymorphism, polymerase chain reaction–restriction fragment length
polymorphism (PCR-RFLP).
